Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II–III

The aim of the present study was to investigate epidermal growth factor receptor (EGFR) mutations as a prognostic factor for postoperative patients with positive EGFR mutations treated with postoperative platinum-based adjuvant chemotherapy (PBAC), and whether two common EGFR mutations exhibit diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Yohei, Okano, Tetsuya, Imai, Kentaro, Maehara, Sachio, Maeda, Junichi, Yoshida, Koichi, Hagiwara, Masaru, Kakihana, Masatoshi, Kajiwara, Naohiro, Ohira, Tatsuo, Matsubayashi, Jun, Ikeda, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876293/
https://www.ncbi.nlm.nih.gov/pubmed/31807168
http://dx.doi.org/10.3892/ol.2019.11050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876293/
https://www.ncbi.nlm.nih.gov/pubmed/31807168
http://dx.doi.org/10.3892/ol.2019.11050

Ejemplares similares